Rivaroxaban OK for stroke prevention in cancer patients

July 13, 2017

(HealthDay)—The safety and efficacy of rivaroxaban treatment for nonvalvular atrial fibrillation (AF) in patients with active cancer is similar to the general population, according to a study published in the July 15 issue of the American Journal of Cardiology.

Eva S. Laube, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues assessed the safety and efficacy of rivaroxaban in 163 patients with active cancer and AF treated from Jan. 1, 2014, to March 31, 2016. Outcomes were assessed from medical records.

After adjusting for competing risks, the researchers found that the estimated one-year cumulative incidence of was 1.4 percent and major bleeding was 1.2 percent. At one year, the risk of clinically relevant nonmajor bleeding leading to discontinuation of anticoagulation was 14.0 percent, while the cumulative incidence of mortality was 22.6 percent, reflecting an active cancer population. There was one death following an acute ischemic cerebrovascular insult.

"The safety and efficacy of rivaroxaban treatment for nonvalvular AF in patients with active is comparable to the results of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET-AF) study in the ," the authors write.

Explore further: Lower risk of gastrointestinal bleeding for apixaban

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Lower risk of gastrointestinal bleeding for apixaban

April 10, 2017
(HealthDay)—For patients receiving direct oral anticoagulant (DOAC) agents for non-valvular atrial fibrillation, apixaban is associated with a lower risk of gastrointestinal (GI) bleeding than rivaroxaban or dabigatran, ...

DAPT use variable in patients with A-fib at risk of stroke

August 16, 2016
(HealthDay)—For patients with atrial fibrillation at moderate to high risk of stroke, dual antiplatelet therapy (DAPT) use is variable among those undergoing percutaneous coronary intervention (PCI), according to a study ...

More GI bleeding seen in atrial fibrillation patients on rivaroxaban than warfarin

October 22, 2012
Patients with atrial fibrillation (AF) experienced more major and non-major clinically relevant GI bleeding when taking rivaroxaban than patients taking warfarin.

Low bleeding and stroke rates in AF patients given rivaroxaban for stroke prevention

September 1, 2015
Atrial fibrillation (AF) patients treated with rivaroxaban for stroke prevention have low rates of bleeding and stroke, reveals real-world data from the XANTUS study presented at ESC Congress today. The findings confirm clinical ...

Well-managed warfarin therapy associated with low risk of complications in patients with atrial fibrillation

April 20, 2016
In a study published online by JAMA Cardiology, Fredrik Björck, M.D., of Umea University, Umea, Sweden and colleagues evaluated the efficacy and safety of well-managed warfarin therapy in patients with nonvalvular atrial ...

Lower inpatient costs for dabigatran, rivaroxaban in A-fib

January 17, 2017
(HealthDay)—For patients with newly diagnosed atrial fibrillation (AF), inpatient costs are lower with dabigatran and rivaroxaban than with warfarin, according to a letter published online in the Jan. 24 issue of the Journal ...

Recommended for you

'Smart stent' detects narrowing of arteries

June 19, 2018
For every three individuals who have had a stent implanted to keep clogged arteries open and prevent a heart attack, at least one will experience restenosis—the renewed narrowing of the artery due to plaque buildup or scarring—which ...

Marriage may protect against heart disease / stroke and associated risk of death

June 18, 2018
Marriage may protect against the development of heart disease/stroke as well as influencing who is more likely to die of it, suggests a pooled analysis of the available data, published online in the journal Heart.

Deaths from cardiac arrest are misclassified, overestimated

June 18, 2018
Forty percent of deaths attributed to cardiac arrest are not sudden or unexpected, and nearly half of the remainder are not arrhythmic—the only situation in which CPR and defibrillators are effective—according to an analysis ...

Tick-borne meat sensitivity linked to heart disease

June 15, 2018
University of Virginia School of Medicine researchers have linked sensitivity to an allergen in red meat—a sensitivity spread by tick bites—with a buildup of fatty plaque in the arteries of the heart. This buildup may ...

Tobacco aside, e-cigarette flavorings may harm blood vessels

June 14, 2018
Flavor additives used in electronic cigarettes and related tobacco products could impair blood vessel function and may be an early indicator of heart damage, according to new laboratory research in Arteriosclerosis, Thrombosis ...

The molecules that energize babies' hearts

June 14, 2018
A metabolic process that provides heart muscle with energy fails to mature in newborns with thickened heart walls, according to a Japan–Canada research team.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.